Cannasouth Ltd. is a biopharmaceutical, research and development company, which develops medicinal cannabis products. It focuses on the commercial development of the medicinally beneficial attributes of cannabinoid compounds such as CBD, THC and associated chemical structures that are produced by the cannabis plant. The company's products include sprays, tablets, patches, topicals, softgels and tinctures. Cannasouth was founded by Mark Lucas and Nic Foreman on August 21, 2018 and is headquartered in Hamilton, New Zealand.